Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability of Plasmodium vivax To Infect Mosquitoes
Transmission-blocking vaccines are one strategy for controlling malaria, whereby sexual-stage parasites are inhibited from infecting mosquitoes by human antibodies. To evaluate whether the recently cloned Plasmodium vivax proteins Pvs25 and Pvs28 are candidates for a transmission-blocking vaccine, t...
Zapisane w:
| Wydane w: | Infect Immun |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
2000
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97758/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11083773/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.68.12.6618-6623.2000 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
